z-logo
Premium
Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [( trans , trans )‐1‐fluoro‐2,5‐bis(3‐hydroxycarbonyl‐4‐hydroxy)styrylbenzene]
Author(s) -
Velasco Ana,
Fraser Graham,
Delobel Patrice,
Ghetti Bernardino,
Lavenir Isabelle,
Goedert Michel
Publication year - 2008
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2008.02.025
Subject(s) - congo red , fluorescence , tau protein , genetically modified mouse , chemistry , derivative (finance) , frontotemporal dementia , inclusion bodies , microtubule , microbiology and biotechnology , transgene , stereochemistry , biochemistry , dementia , biology , alzheimer's disease , gene , disease , pathology , medicine , physics , organic chemistry , adsorption , quantum mechanics , escherichia coli , financial economics , economics
Filamentous inclusions made of the microtubule‐associated protein tau in a hyperphosphorylated state are a defining feature of a large number of human neurodegenerative diseases. Here we show that ( trans , trans )‐1‐fluoro‐2,5‐bis(3‐hydroxycarbonyl‐4‐hydroxy)styrylbenzene (FSB), a fluorescent Congo red derivative, labels tau inclusions in tissue sections from a mouse line transgenic for human P301S tau and in cases of familial frontotemporal dementia and sporadic Pick's disease. Labelling by FSB required the presence of tau filaments. More importantly, tau inclusions in the spinal cord of human P301S tau transgenic mice were labelled following a single intravenous injection of FSB. These findings indicate that FSB can be used to detect filamentous tau in vivo.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom